Daily Roundup
Tuesday, 4th February 2025
Last updated: 21:00
BMT.ASX PME.ASX PNI.ASX XF1.ASX IMB.ASX
Market Roundup: New CEO at Beamtree, Major Contract for Pro Medicus, and More
Beamtree Appoints New CEO
Beamtree Holdings Limited has announced the appointment of Marek Stepniak as its new Chief Executive Officer, effective early March 2025. Marek brings extensive experience in the healthcare sector, having led hospital groups and health technology organizations across 30 countries. He has been with Beamtree for the past 18 months as Chief Growth Officer, spearheading the company's successful expansion into international markets. Retiring CEO Tim Kelsey will remain with Beamtree as a part-time senior advisor, focusing on business development in international markets.
Pro Medicus Signs Major Contract with BayCare
Pro Medicus Limited (PME) has signed a A$53 million, 7-year contract with BayCare, the leading healthcare system in the Tampa Bay and central Florida regions. The contract will see PME's Visage 7 Enterprise Imaging Platform, including the Visage 7 Viewer and Workflow modules, implemented throughout the BayCare system. This continues PME's expansion into the North American Integrated Delivery Network (IDN) market, with Visage 7 now being used by 70% of all Visage 7 North American clients.
Pinnacle Investment Management Reports Strong Half-Year Results
Pinnacle Investment Management Group Ltd has reported a strong financial performance for the half-year ended 31 December 2024. The company saw a 16.7% increase in revenues from ordinary activities to $27,643, and a 150.5% increase in profit from continuing operations after tax attributable to shareholders to $75,707. Earnings per share on a statutory basis also increased by 139.6% to 36.9 cents. Pinnacle has continued to grow its portfolio of associate and joint venture entities, which contributed significantly to the company's results.
Xref Scheme of Arrangement with SEEK Not Approved
Xref Ltd's proposed scheme of arrangement with SEEK Ltd was not approved at the Scheme Meeting, despite 78.82% of shareholders voting in favor. The 75% vote threshold was not met, and the Scheme Implementation Deed has been terminated. Xref will continue to execute its growth strategy as an independent business.
Intelligent Monitoring Group Secures Debt Refinancing
Intelligent Monitoring Group Ltd (IMB) has secured a new $122.5 million debt facility from NAB, reducing its interest rate from 15% to approximately 7% and saving over $6.5 million per year. This strengthens the company's balance sheet and provides up to $37.5 million in additional firepower for potential EBITDA-accretive acquisitions.
References
BMT.ASX | 09:02 | Beamtree appoints new CEO |
PME.ASX | 10:16 | PME signs A$53M, 7-year contract with BayCare |
PNI.ASX | 16:27 | Appendix 4D |
XF1.ASX | 08:21 | Scheme Meeting Results |
IMB.ASX | 09:12 | IMB Debt Refinancing |